For aspiration pneumonia, first-line therapy targets anaerobes. Which regimen is appropriate?

Prepare for the PANCE Precision Exam. Study with flashcards and multiple choice questions, each question has explanations and tips. Ensure success on your exam!

Multiple Choice

For aspiration pneumonia, first-line therapy targets anaerobes. Which regimen is appropriate?

Explanation:
Anaerobic bacteria from the oropharynx commonly contribute to aspiration pneumonia, so initial therapy should cover anaerobes as well as typical aerobic pathogens. Ampicillin-sulbactam IV combines a beta-lactam antibiotic with a beta-lactamase inhibitor, giving reliable anaerobic coverage plus activity against common Gram-positive cocci and some Gram-negative rods. This makes it appropriate as first-line therapy for aspiration pneumonia, especially in more serious cases. Amoxicillin alone lacks sufficient anaerobic coverage, so it may miss the key anaerobes involved. Metronidazole alone targets anaerobes but misses many aerobic pathogens part of aspiration flora. Cefdinir provides limited anaerobic activity and isn’t reliably effective against the anaerobes typical of aspiration pneumonia.

Anaerobic bacteria from the oropharynx commonly contribute to aspiration pneumonia, so initial therapy should cover anaerobes as well as typical aerobic pathogens. Ampicillin-sulbactam IV combines a beta-lactam antibiotic with a beta-lactamase inhibitor, giving reliable anaerobic coverage plus activity against common Gram-positive cocci and some Gram-negative rods. This makes it appropriate as first-line therapy for aspiration pneumonia, especially in more serious cases.

Amoxicillin alone lacks sufficient anaerobic coverage, so it may miss the key anaerobes involved. Metronidazole alone targets anaerobes but misses many aerobic pathogens part of aspiration flora. Cefdinir provides limited anaerobic activity and isn’t reliably effective against the anaerobes typical of aspiration pneumonia.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy